Altern'...Getin_PR''timed..unusual.@11:45.-did.'Seem,,a-hold'em...'heads-up+ The game changer is more than any dividend which is coming .
Actually there has cone a time to see the injections pr which should get more new buyers interest There is interest in the profit split The EMA for approvals plann in Europe wanted a kinetics study which was said on track . Also..There was said a treaty with Europe and US to accept data for fda to use here
There is a clinical study now set up in Sept for Diabetes This cost big bucks to do .. there would be reason to think it Had factors that showed up with evidence the immune modulator Effect had diabetes as a game changer and maybe type 1 With pancreas damaged and maybe a break in that enormous market